As more states legalize cannabis, increasingly stringent testing requirements are being developed on the state level for pesticide and mycotoxin levels in cannabis products. Cannabis is a very complex matrix, which makes testing to the specified levels a challenge for many laboratories. Avinash Dalmia, a principal R&D Scientist with PerkinElmer, has been working to solve this problem using a liquid chromatography–tandem mass spectrometry (LC–MS/MS) method with electrospray ionization (ESI) and atmospheric pressure chemical ionization (APCI). Here, Dalmia discusses that research and previews an upcoming paper on the topic for our September issue.
In an upcoming article for Cannabis Science and Technology (1), you present a liquid chromatography–tandem mass spectrometry (LC–MS/MS) method with electrospray ionization (ESI) and atmospheric pressure chemical ionization (APCI) to meet cannabis pesticide and mycotoxin residues regulatory requirements in California. How did you get started with that research?
When I started working on cannabis analysis, Oregon cannabis testing labs were struggling with their pesticide methods because of matrix interference. My goal was to address this challenge by developing a fast, sensitive, and validated LC–MS/MS method. I selected to leverage both the ESI and APCI ionization techniques, and optimum multiple reaction monitoring (MRM) transitions, that would allow low level analysis of all of pesticides and mycotoxins regulated by both California and Oregon. An extensive examination of peer-reviewed research literature suggested that some of the nonpolar and chlorinated pesticides, such as chlordane and pentachloronitrobenzene on the California list, cannot be analyzed with LC–MS/MS. As a scientist, I like to work on things that have never been done before and welcomed the challenge. After validation testing of this method with multiple cannabis testing labs and PerkinElmer scientists, I am excited to demonstrate that we can analyze these hydrophobic and chlorinated pesticides at low levels in cannabis with LC–MS/MS. Secondly, it is important to prevent public health risks from consumption of cannabis products tainted with high levels of pesticides. Therefore, by developing an analytical method for pesticides and mycotoxins analysis in cannabis, we can help ensure that cannabis products can meet current state safety regulations, making cannabis safe to consume for both medical and recreation purposes.
What specific challenges do you face when analyzing cannabis pesticide and mycotoxin residues compared to other samples?
Pesticide analysis in cannabis is extremely challenging since the matrix composition is very complex and contains compounds at various concentration levels from different classes such as cannabinoids, terpenes, hydrocarbons, sugars, fatty acids, flavonoids, and others. The complex cannabis matrix leads to ion suppression and matrix interference, and therefore cannabis extracts need to be diluted by an overall factor of 10 in acetonitrile to reduce matrix effects. This dilution means that if you want to detect a pesticide at a level of 100 ppb or lower in cannabis, your method would need to measure pesticides at a level of 10 ppb or lower in the cannabis extract because of the overall dilution factor of 10 during extraction. Also, conventional MRM transitions, used for analysis of some of pesticides in other relatively cleaner matrices, could not be deployed for pesticide analysis in cannabis because of matrix interference. Therefore, to ensure the highest sensitivity, MRM transitions for a number of pesticides with minimal matrix interference in the cannabis matrix were determined for low level detection. For example, acequinocyl is an insecticide and can be ionized easily as a protonated molecular ion in a standard matrix, but the MRM transitions, based on protonated molecular ion in the cannabis matrix, showed poor limits of quantitation (LOQ) of 0.5–1 ppm, about 5–10 times higher than its action limit for the state of California. Therefore, MRM transitions based on alternative modes of ionization, such as adduct formation, were determined to reduce matrix interference and achieve an LOQ of 25 ppb (four times below California action limits) for acequinocyl in the cannabis matrix.
Because of the cannabis matrix’s hydrophobicity, further dilution of the extract cannot be performed with the aqueous mobile phase to make it compatible with reversed-phase columns. This dilution protocol, compatible with other matrices, resulted in lower recoveries of some pesticides in the nonpolar cannabis matrix. However, the reversed-phase LC method uses aqueous mobile phase at the beginning of the LC run to help better retain the polar compounds on the column. Injecting an organic solvent such as an acetonitrile extract of cannabis on the LC leads to poor chromatographic peaks for early eluted polar compounds in reversed-phase LC. To overcome this problem, a small sample injection volume (microliters) of cannabis extract in optimum organic solvent with a reversed-phase LC column was used in our work. Typically, the dirty matrix in cannabis samples would quickly foul the conventional gas chromatography–tandem mass spectrometry (GC–MS/MS) and LC–MS/MS systems, which would increase the maintenance costs and downtime and result in a loss of productivity. I worked with my company’s engineering and product development team to help design and evaluate a new ionization source to reduce the need for maintenance and enable more uptime for the analysis of pesticides in dirty cannabis matrices.
What are the advantages of the LC–MS/MS method compared with other previously used methods for the analysis of pesticides and mycotoxins in cannabis?
LC–MS/MS has emerged as the method of choice for pesticide and mycotoxin analysis because it offers superior selectivity, sensitivity, ruggedness, and does not require extensive sample preparation and derivatization before analysis. LC–MS/MS methods can be utilized for analysis of all of pesticides and mycotoxin residues with different polarities and molecular weights. Other methods are only applicable to a smaller number of pesticides and mycotoxins. Compounds such as daminozide, a highly polar compound, and abamectin, a high-molecular-weight compound, are not amenable to analysis by GC–MS/MS because they are heat labile and degrade in either the GC injection port or the column at high temperature. GC–MS/MS methods are not as robust as LC–MS/MS methods for pesticide analysis in complex matrices since they require extensive sample preparation to prevent GC injection port contamination from complex matrices.
How do the regulations in California differ from other states? Have you developed specific methods for each state that has cannabis pesticide and mycotoxin residues regulatory requirements?
Great question, and the answer is yes. PerkinElmer has developed specific methods for varying state requirements so testing labs are confident about meeting their own state’s regulations. Oregon was one of the first states in the U.S. to issue comprehensive guidelines for pesticide residues analysis in cannabis, and set regulatory limits for 59 pesticides. California issued more stringent action limits (about a factor of 2 to 20 lower than Oregon state action limits) for 66 pesticides (including all but one of those found on Oregon state list, and eight more) and five mycotoxin residues in cannabis flower and edibles. We have developed LC–MS/MS methods that meet both Oregon and California state pesticide and mycotoxin regulatory requirements. I continue to work on forthcoming regulation limits, such as the Health Canada pesticide requirements, which are even lower than California’s.
What do you think readers will learn from your article in Cannabis Science and Technology (1)?
Here are the key results that address a number of the challenges with this this method:
What are the next steps in your cannabis research?
This summer the government in Canada passed a federal law to allow its residents to use cannabis for medical and recreation purposes. Canada has issued more stringent regulatory limits for a bigger panel of pesticide residues in cannabis flower, oil, and fresh plants. To support our Canadian cannabis clients our application team is developing a new LC–MS/MS method to address very low regulatory limits set by Health Canada for pesticide residue analysis in cannabis flowers. Next, we will validate our LC–MS/MS method on a variety of cannabis-related matrices such as cannabis concentrates, edibles, and hemp.
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part II
December 17th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election, including state and federal policies and possible paths forward for testing standardization. Join us in the second part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Cannabis, US Presidential Election 2024, and Beyond: A Roundtable Discussion, Part I
December 16th 2024With the recent 2024 presidential election behind us, the future of cannabis still has many unknowns moving forward and questions still to be discussed. In this roundtable discussion with four knowledgeable industry leaders, we explore the nuanced political landscape of cannabis legalization and rescheduling in the context of the election. We discuss what drives support or opposition from both sides of the aisle, the complexities of balancing state and federal priorities, and more. Join us in the first part of a compilation of responses from Kim Anzarut, CQA, CP-FS, CEO of Allay Consulting; Susan Audino, PhD, founder of S.A. Audino & Associates, LLC; Zacariah Hildenbrand, PhD, research Professor at the University of Texas at El Paso; and David Vaillencourt, CEO of The GMP Collective.
Empowering Women in Cannabis: Susan Audino, PhD, on Inclusivity, Integrity, and Industry Challenges
December 11th 2024Founder of S. A. Audino & Associates, LLC, Susan Audino, PhD, recently co-founded Saturn Scientific, LLC, a collaboration of five experienced individuals providing unbiased evaluations on the data and science for stakeholders in the cannabis industry. In this interview with Cannabis Science and Technology, Dr. Audino shares her unexpected path into analytical science and the cannabis industry as well as the obstacles she’s faced throughout her career. She highlights the gender bias she’s observed, such as unequal recognition of credentials and workplace challenges, while advocating for inclusivity and mentorship to empower women in science. Additionally, Dr. Audino recounts her experiences of navigating the male-dominated cannabis space, pushing for transparency, collaboration, and integrity in laboratory practices. Ultimately, Audino believes fostering mutual respect and knowledge-sharing is vital for the industry’s growth and resilience.
Collaboration, Gender Diversity, and Progress: Julie Kowalski on Advancing Cannabis Science
December 10th 2024In this interview with Cannabis Science and Technology, Julie Kowalski, an experienced analytical chemist, discusses her path into the cannabis industry, starting with early work in gas chromatography. Kowalski reflects on her perspectives as a female scientist, highlighting biases she’s experienced and the benefits of gender inclusivity in the cannabis space. Greater unity and professionalism could benefit the industry as a whole, she explains. She also encourages collaboration and more women in leadership positions in order to build a stronger scientific community, and also urges women to advocate for themselves, noting that women in cannabis face unique obstacles but often demonstrate consensus-building strategies and solutions.